首页> 中文期刊> 《检验医学与临床》 >CT导向脑立体定向血肿清除术治疗高血压脑出血的探讨

CT导向脑立体定向血肿清除术治疗高血压脑出血的探讨

         

摘要

目的:探讨 CT 导向脑立体定向血肿清除术治疗高血压脑出血的临床疗效。方法选取2012年2月至2014年6月本院收治的80例高血压脑出血的患者,所有患者均根据第4届脑血管病会议的标准和影像学检查已确诊。根据患者选择手术方法的不同分为观察组和对照组,采用 CT 导向脑立体定向血肿清除术进行治疗的40例患者为观察组,采用常规的立体定向血肿清除术的治疗40例患者为对照组。结束治疗后,对两组患者脑出血量、偏瘫恢复时间情况、病死率及两组患者临床疗效情况进行比较分析。结果在经过治疗之后,观察组患者的脑出血量、偏瘫恢复时间及病死率均明显低于对照组;观察组患者的治疗疗效明显高于对照组,差异有统计学意义(P <0.05)。结论 CT 导向脑立体定向血肿清除术治疗高血压脑出血患者,不仅具有创伤小、手术时间短、安全性高、定位精确和疗效确切等优点,而且能够突出临床的治疗效果,提高患者的生活质量,保障患者的生命安全,值得临床推广应用。%Objective To investigate the effect of CT guided stereotactic hematoma evacuation for treating hy-pertensive intracerebral hemorrhage .Methods Eighty cases of hypertensive intracerebral hemorrhage in our hospital from February 2012 to June 2014 were selected and diagnosed according to the criteria in the Fourth National Confer-ence of Cerebrovascular Disease and imaging examination .The patients were divided into the observation group and the control group according to different selected operation methods .Forty cases treated by adopting CT guided ster-eotactic hematoma evacuation were taken as the observation group ,while other 40 cases treated by adopting the rou-tine stereotactic hematoma evacuation were as the control group .The cerebral hemorrhage amount ,hemiplegia recov-ery time ,mortality and clinical efficacy after treatment were compared between the two groups .Results After treat-ment ,the cerebral hemorrhage amount ,hemiplegia recovery time and mortality rates in the observation group were significantly lower than those in the control group ;the curative effect in the observation group was significantly high-er than that in the control group with statistically significant difference (P< 0 .05) .Conclusion CT-guided stereotac-tic hematoma evacuation for treating hypertensive intracerebral hemorrhage not only has the advantages of small trau-ma ,short operation time ,high safety ,precise positioning and definite curative effect ,etc .,but also highlights the clini-cal curative effect ,increases the living quality of patients and ensures the life safety of patients ,which is worthy of be-ing clinically promoted and applied .

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号